MedPlus Health Services has received a favorable court ruling for one of its company units in Telangana. The healthcare retail company announced this positive legal development, though specific details about the court case have not been disclosed.

Legal Development

The court ruling represents a positive outcome for the company's operations in Telangana. However, the nature of the legal proceedings, the specific court involved, and the detailed implications of the judgment have not been made public by the company.

Company Operations

MedPlus Health Services operates as a pharmacy retail chain across multiple states in India. The company's presence in Telangana appears to have been subject to legal proceedings that have now concluded favorably for the organization.

MedPlus Health Services Limited has disclosed to stock exchanges that its subsidiary company has received a regulatory action from Karnataka's drug control authorities. The company filed the disclosure on December 10, 2025, in compliance with SEBI listing regulations.

Regulatory Action Details

Optival Health Solutions Private Limited, a subsidiary of MedPlus Health Services, received a suspension order for its drug license from the Assistant Director, Drugs Control Administration, Hubli Circle-Hubli, Karnataka. The order was received on December 9, 2025.

Legal Framework and Compliance

The suspension order was issued under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company has disclosed this information pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, read with SEBI Circular SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024.

Financial Impact

The company has quantified the potential financial impact of this regulatory action:

Disclosure and Transparency

MedPlus Health Services has ensured proper disclosure of this regulatory development across multiple platforms. The information has been made available on the company's official website at www.medplusindia.com , as well as on the websites of both stock exchanges - BSE Limited ( www.bseindia.com ) and National Stock Exchange of India Limited ( www.nseindia.com ). The disclosure was signed by Manoj Kumar Srivastava, Company Secretary and Compliance Officer, demonstrating the company's commitment to regulatory compliance and transparency with stakeholders.